Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03786042 · ClinicalTrials.gov registry record · NA
Trial on the Effect of E-cigarette Advertising on Cigarette Perceptions in Adolescents
A NA study of Social Norms and Attentional Bias, sponsored by Trustees of Dartmouth College.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
- 1
- Study location
NCT03786042: Completed NA study of Social Norms and Attentional Bias, sponsored by Trustees of Dartmouth College.
NCT03786042 is a NA study of Social Norms and Attentional Bias that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 139 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03786042, a NA study of Social Norms and Attentional Bias, has completed, sponsored by Trustees of Dartmouth College.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to investigate how exposure to advertising for Electronic Nicotine Delivery Systems (commonly called e-cigarettes) may lead to combustible smoking initiation in adolescents.
Primary Outcome
Scores are measured by recording the amount of time (milliseconds) it takes to categorize smoking-related words with positive (e.g., cool) and negative (e.g., cancer) words. Faster reaction times when categorizing smoking-related words with positive words is evidence of higher positive smoking expectancies.
Conditions Studied
Interventions
- BEHAVIORAL E-cigarette ad exposure
- OTHER non e-cigarette TV commercials
Study Locations (1)
New Hampshire
- Dartmouth-Hithchock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2021-12-09 |
| Phase | NA |
What the finished NCT03786042 record still lists
NCT03786042 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 5 conditions, with Social Norms appearing as the primary indexed condition, and to 2 interventions - of which E-cigarette ad exposure is the first listed.
NCT03786042 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT03786042 about?
NCT03786042 is a clinical study titled "Trial on the Effect of E-cigarette Advertising on Cigarette Perceptions in Adolescents". This research aims to investigate how exposure to advertising for Electronic Nicotine Delivery Systems (commonly called e-cigarettes) may lead to combustible smoking initiation in adolescents.
What is the current status of trial NCT03786042?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2019-02-04. Estimated completion is 2021-12-09.
What conditions does trial NCT03786042 study?
This clinical trial studies the following conditions: Social Norms, Attentional Bias, Smoking Cues, Positive Perceptions About Cigarette Smoking, Smoking Susceptibility.
What interventions are being tested in trial NCT03786042?
The interventions under investigation include: E-cigarette ad exposure (BEHAVIORAL), non e-cigarette TV commercials (OTHER).
Who is sponsoring clinical trial NCT03786042?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03786042 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Norms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03786042's enrollment target sits among peer trials
139 720th of 2000 higher than 1,281 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI